Lithuania joined BBMRI-ERIC on 15th April 2020, and nominated the National cancer institute (NCI) as the Lithuanian National Biobank Node (BBMRI.lt; LBN). LBN is the umbrella organisation of biobanks in Lithuania that represents the interests of Lithuanian biobanks within BBMRI-ERIC network. LBN is also the primary contact point in Lithuania for all stakeholders in biobanking.
Under the leadership of National Cancer Institute (NCI), 6 institutions work together on the project “Human Biological Resource Center” to create a common visionary infrastructure, empower human resources, scientific expertise and stimulate biobaking activities in the country. LBN aims to create a harmonised, efficient and leading biobank infrastructure, an open access research platform, that boosts Lithuanian biomedical research, healthcare, and biomedical industry while fastering integration to the European Research Area.
Currently, national biobank gathers, maintains and processes mainly cancer related biological material, including tissue, blood, serum, plasma, cell, DNA and RNA and associated clinical, demographical data. Over 16 000 samples are cumulated and stored over recent years in biobank. This number will increase with extended inclusion of biological material from different participant segments: diseased, population-based and healthy volunteers.
The main areas Lithuanian Biobank Node will focus on :